PURPOSE: To assess the depth of infiltration of rectal cancer with transrectal ultrasound (US) (TRUS) and analyze interpretation errors. MATERIALS AND METHODS: Fifty-five consecutive patients with rectal cancer who underwent TRUS were prospectively studied. The effect of different patient inclusion criteria and US criteria was evaluated retrospectively. RESULTS: Extensive overstaging of T2 tumors, partially caused by inflammatory (desmoplastic) reaction or retraction of the muscularis propria, resulted in a specificity of only 24% for detection of perirectal infiltration. Sensitivity was 97%, and accuracy was 64%. Considerable variation in staging accuracy was observed when different patient selection criteria were used. Variation of US criteria improved differentiation between T2 and T3 tumors only slightly. CONCLUSION: The effect of different US criteria on differentiation of T2 and T3 tumors is limited. Spontaneous or iatrogenic inflammation is a major limiting factor. The accuracy of TRUS in staging rectal cancer is affected by patient inclusion criteria.
PURPOSE: To assess the depth of infiltration of rectal cancer with transrectal ultrasound (US) (TRUS) and analyze interpretation errors. MATERIALS AND METHODS: Fifty-five consecutive patients with rectal cancer who underwent TRUS were prospectively studied. The effect of different patient inclusion criteria and US criteria was evaluated retrospectively. RESULTS: Extensive overstaging of T2 tumors, partially caused by inflammatory (desmoplastic) reaction or retraction of the muscularis propria, resulted in a specificity of only 24% for detection of perirectal infiltration. Sensitivity was 97%, and accuracy was 64%. Considerable variation in staging accuracy was observed when different patient selection criteria were used. Variation of US criteria improved differentiation between T2 and T3 tumors only slightly. CONCLUSION: The effect of different US criteria on differentiation of T2 and T3 tumors is limited. Spontaneous or iatrogenic inflammation is a major limiting factor. The accuracy of TRUS in staging rectal cancer is affected by patient inclusion criteria.
Authors: Suk Hee Heo; Jin Woong Kim; Sang Soo Shin; Yong Yeon Jeong; Heoung-Keun Kang Journal: World J Gastroenterol Date: 2014-04-21 Impact factor: 5.742
Authors: Pietro Marone; Mario de Bellis; Valentina D'Angelo; Paolo Delrio; Valentina Passananti; Elena Di Girolamo; Giovanni Battista Rossi; Daniela Rega; Maura Claire Tracey; Alfonso Mario Tempesta Journal: World J Gastrointest Endosc Date: 2015-06-25
Authors: Christopher G Willett; Dan G Duda; Emmanuelle di Tomaso; Yves Boucher; Brian G Czito; Zeljko Vujaskovic; Gordana Vlahovic; Johanna Bendell; Kenneth S Cohen; Herbert I Hurwitz; Rex Bentley; Gregory Y Lauwers; Martin Poleski; Terence Z Wong; Erik Paulson; Kirk A Ludwig; Rakesh K Jain Journal: Nat Clin Pract Oncol Date: 2007-05